We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

851. Deputy Conor Sheehan asked the Minister for Health the steps being taken, in conjunction with the HSE, to address the ongoing delays in clinical assessments for adults with Spinal Muscular Atrophy (SMA) who are seeking access to the newly reimbursed treatment risdiplam. [78941/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this